This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Isis Innovation Limited, Oxford University Innovation Ltd. Active years: 2015-2017.
Company Filing History:
Years Active: 2015-2017
Title: Joseph Illingworth: Innovator in Malaria Treatment
Introduction
Joseph Illingworth is a notable inventor based in Matlock, GB. He has made significant contributions to the field of malaria treatment, holding 2 patents that focus on innovative approaches to combat this disease. His work is characterized by the development of antigens and vectors that play a crucial role in the prevention and treatment of malaria.
Latest Patents
Illingworth's latest patents revolve around the treatment and prevention of malaria. These patents provide antigens, vectors encoding the antigens, and antibodies, along with other binding compounds to the antigens. The compositions include a Reticulocyte-binding protein Homologue 5 (PfRH5) antigen that has at least 90% identity with SEQ ID NO: 1, or a fragment thereof. Additionally, they comprise a viral vector that expresses the PfRH5 antigen with at least 90% identity with SEQ ID NO: 2, or a fragment thereof. This innovative approach aims to enhance the efficacy of malaria treatment and prevention strategies.
Career Highlights
Throughout his career, Joseph Illingworth has worked with prominent organizations such as Isis Innovation Limited and Oxford University Innovation Ltd. His experience in these companies has allowed him to develop and refine his inventions, contributing to advancements in medical research and innovation.
Collaborations
Some of Illingworth's notable coworkers include Alexander Douglas and Simon Draper. Their collaboration has likely fostered a productive environment for innovation and research in the field of malaria treatment.
Conclusion
Joseph Illingworth's contributions to malaria treatment through his patents and collaborations highlight his commitment to addressing global health challenges. His innovative work continues to pave the way for advancements in medical science.